Similarly, the results shown in Figure 7B and 7C indicated that iNOS expression was inhibited in the diabetes group (p < 0.05), whereas CAPE and CAPE-pNO2 up-regulated iNOS expression; again, CAPE-pNO2 had better effects than CAPE (p < 0.05). The gene discussed is NOS2; the disease is diabetes mellitus.